UPC APP 8391/2024

—·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Roche Diabetes Care GmbH
Vertreter: Christof Augenstein (Kather Augenstein); Katharina Brandt (Kather Augenstein); Robert Knaps (Kather Augenstein); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte PartGmbH)
Beklagte
Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.
Vertreter: Charlotte Garnitsch (Taylor Wessing); Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Division: Paris CD
Richter: Paolo Catallozzi · Presiding judge and judge-rapporteur
Technology: Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 20. Feb. 2024

Entscheidungen

2024-02-20
Generic application
The Central Division Paris seat granted Roche Diabetes Care GmbH's request for an extension of the time period for filing the defence to revocation in the pending revocation action concerning EP 2 196 231, pending a decision on the preliminary objection to jurisdiction.
Rechtsfragen:Extension of time period for defence to revocationPreliminary objection to jurisdictionProcedural order

Dokumente